COVID-19 Innovation Conference - Worldwide Online Investment Event
Proudly Supported By
CEO, ContinUse Biometrics
Researcher, LIFT (Technion)
Co-founder & CEO, MedCu
Chief Scientist, Ministry of Economy and Industry & Chairman, Israel Innovation Authority
(MD, MSc) Deputy General Director, Chief Medical Officer and Chief Innovation Officer – Sheba Hospital (Tel Hashomer, Is
(PhD), Chairman and CEO at CanSino Biologics (Tianjin, China) (evening session)
Chairman, Cukierman & Co. Investment House
(MD) Director of Respiratory Care - Zhejiang University, Sir Run Run Shaw hospital (Hangzhou, China)
Managing Partner, Cukierman & Co. Life Sciences
(PhD) VP for External Relations & Resource Development, Professor of Mechanical and Biomedical Engineering, Technion Isr
Prof. Dror Mevorach, M.D., Chief Scientific & Medical Officer – Enlivex (Ness Ziona, Israel)
Executive Chairman, Enlivex
Partner, Cukierman & Co. Life Sciences
(MD, Dr.Sc., MPH), VP & CSO, Meinian OneHealth Group & Executive Director, Peking University Meinian Public Health Resea
Technion COVID-19 Emergency Fund - DONATE
Technion Researchers on the Frontline in the Fight against COVID-19 Technion scientists mobilized in the worldwide effort to find solutions for the current global health crisis.
Aero41, Delta Drone Group
High precision AI-driven disinfection flying robot
Causaly AI is the only biomedical search tool that allows researchers to 'read' the entire body of published scientific literature, and find answers to questions in seconds that otherwise take weeks or months in research time.
Cukierman & Co. Life Sciences
Cukierman & Co. Life Sciences (CLS) provides services to companies across healthcare and are mandated by biotechnology, pharmaceuticals, diagnostics, medical devices and digital health companies. Established in 2006 as the Life Sciences arm of Cukierman & Co. Investment House, CLS offers investment banking services to private and public companies at different stages of their development.